Kate Hunter concentrates her practice on investigations and litigation related to inquiries involving alleged violations of the False Claims Act (FCA), the Foreign Corrupt Practices Act (FCPA), various securities laws and other federal statutes. She represents healthcare companies in responding to government investigations concerning issues of alleged healthcare fraud and abuse. She regularly counsels clients on compliance with the FCA and defends clients related to various state and federal agency investigations.
In addition, Kate helps clients stay up-to-date on regulatory developments related to corporate compliance matters and assists clients in conducting internal investigations and preparing and implementing anti-corruption compliance programs.
Prior to joining Bass, Berry & Sims, Kate was an associate in the Washington, D.C. office of Norton Rose Fulbright. Kate earned her law degree and an LL.M. in international and comparative law from Duke University School of Law. She earned a B.A. in international relations and economics from Tufts University.
American Health Lawyers Association (AHLA)
Represented CenseoHealth in its sale to New Mountain Capital
Lead counsel representing Medicare Advantage service provider in qui tam that alleged that defendants caused the inflation of risk adjustment scores. U.S. ex rel. Ramsey v. Censeo Health, L.L.C., No. 3:14-cv-118 (N.D. Tex.)
Phi Beta Kappa
Duke Journal of Comparative & International Law – Editor-in-Chief